As of 2026-03-03, the EV/EBITDA ratio of Puma Biotechnology Inc (PBYI) is 5.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PBYI's latest enterprise value is 267.41 mil USD. PBYI's TTM EBITDA according to its financial statements is 45.83 mil USD. Dividing these 2 quantities gives us the above PBYI EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 15.2x | 14.9x |
| Forward P/E multiples | 19.0x - 23.7x | 21.5x |
| Fair Price | 12.58 - 16.89 | 14.66 |
| Upside | 120.7% - 196.3% | 157.2% |
| Date | EV/EBITDA |
| 2026-02-27 | 5.83 |
| 2026-02-26 | 7.92 |
| 2026-02-25 | 8.01 |
| 2026-02-24 | 7.80 |
| 2026-02-23 | 7.38 |
| 2026-02-20 | 7.08 |
| 2026-02-19 | 7.03 |
| 2026-02-18 | 6.91 |
| 2026-02-17 | 6.99 |
| 2026-02-13 | 7.07 |
| 2026-02-12 | 7.04 |
| 2026-02-11 | 6.87 |
| 2026-02-10 | 6.84 |
| 2026-02-09 | 7.13 |
| 2026-02-06 | 7.20 |
| 2026-02-05 | 7.03 |
| 2026-02-04 | 7.37 |
| 2026-02-03 | 7.37 |
| 2026-02-02 | 7.07 |
| 2026-01-30 | 6.69 |
| 2026-01-29 | 6.64 |
| 2026-01-28 | 6.52 |
| 2026-01-27 | 6.79 |
| 2026-01-26 | 6.64 |
| 2026-01-23 | 6.63 |
| 2026-01-22 | 7.11 |
| 2026-01-21 | 7.14 |
| 2026-01-20 | 6.82 |
| 2026-01-16 | 6.57 |
| 2026-01-15 | 6.58 |
| 2026-01-14 | 6.63 |
| 2026-01-13 | 6.43 |
| 2026-01-12 | 6.47 |
| 2026-01-09 | 6.29 |
| 2026-01-08 | 6.38 |
| 2026-01-07 | 6.26 |
| 2026-01-06 | 6.01 |
| 2026-01-05 | 6.10 |
| 2026-01-02 | 5.91 |
| 2025-12-31 | 6.11 |
| 2025-12-30 | 6.18 |
| 2025-12-29 | 6.26 |
| 2025-12-26 | 6.34 |
| 2025-12-24 | 6.12 |
| 2025-12-23 | 6.07 |
| 2025-12-22 | 5.98 |
| 2025-12-19 | 5.76 |
| 2025-12-18 | 5.75 |
| 2025-12-17 | 5.70 |
| 2025-12-16 | 5.80 |